US 11819554
Compositions and methods for modulating FMR1 expression
granted A61KA61K31/167A61K31/404
Quick answer
US patent 11819554 (Compositions and methods for modulating FMR1 expression) held by Fulcrum Therapeutics, Inc. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fulcrum Therapeutics, Inc.
- Grant date
- Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/167, A61K31/404, A61K31/437, A61K31/4406